Please login to the form below

Not currently logged in
Email:
Password:

Accretio appoints Neil Levinson as strategy director

He joins the healthcare consultancy from Kaiser Associates

AccretioAccretio, part of the OPEN health group of companies, has appointed Neil Levinson as its strategy director.

Levinson will join the Accretio leadership team alongside managing director Richard Baderin and operations director Charlotte Richards.

Speaking of his new appointment, Levinson said: “Accretio has pioneered novel ways to support life science companies achieve improved results for their brand.

“I look forward to expanding this offering and maximising the breadth of experience from the broader OPEN Health group to provide outcomes-focused consulting and implementation services for global and UK clients.”

Most recently, Levinson was vice president at Kaiser Associates, a global strategy-consulting firm, where he led the European healthcare practice.

Prior to Kaiser, Levinson spent ten years at IMS Health, where he was senior principal, leading the UK and Ireland consulting services business.

Commenting on his appointment, Baderin, said: “Neil’s appointment cements Accretio’s evolution to a fully-fledged strategic solutions and implementation services company led by a team with pharmaceutical, consultancy and agency heritage.

“It’s great to have someone of Neil’s calibre as part of the leadership team as we embark on the next phase of Accretio’s journey.”

24th April 2018

From: Marketing

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Creative Medical Research

Specialising in medical device market research and participant recruitment human factors research, our approach is people-centric. We thrive on making...

Latest intelligence

Five companies 20 for 2020
20 for 2020 – Five pharma companies to watch
As a new decade gets into gear, we take a look at five pharma companies that have a lot riding on 2020...
The growing clinical importance of patient-reported outcomes (PROs)
Traditionally, the success or otherwise of medical treatments has been assessed by mortality or clinical assessments of health. However, patient self-reports of health are increasingly seen as central to the...
Generation Z
The roaring ‘20s and Generation Z
How a new generation will shape pharma comms this decade...

Infographics